Case Study B
Antimicrobial Resistance (AMR) Forecasting in Uganda and Germany and Integration into healthcare systems
About
The primary goal of this Case Study is to test and refine forecasting technologies within AMS frameworks in two distinct healthcare settings - Germany and Uganda. These countries serve as proxies for high- and low-income settings, respectively, and provide a comparative landscape to assess how forecasting technologies can be implemented and scaled across diverse healthcare systems. By testing the forecasting device in parallel in Uganda and Germany, we aim to understand how factors like healthcare infrastructure, antibiotic availability, and microbiological capabilities influence the integration and effectiveness of these tools in AMS programs.
Work Packages
Technology Integration Framework For Forecasting AMR In AMS
Ethical And Context-sensitive Design Of Evolchip
Comparative Technology Evaluation to Ensure Applicability in Uganda and Germany
Methods
- Technological prototype testing and refinement in laboratory environments using the novel forecasting tool EvolChip
- Comparative analysis betweed Uganda & Germany
- Systematic review of AMS protocols, workflows and best practices
- Semi-structured qualitative interviews with key stakeholders
- Participatory workshops within living lab
Expected Outcomes
- Framework for the integration of forecasting technologies into AMS programs in diverse healthcare system contexts.
- Tailored AMS training and educational resources.
- Guidelines for scaling and transferring the technology to other healthcare systems.
- Refined EvolChip prototype shaped by real-world user-centered testing.
Involved Institutions
